(165 days)
The SCENARIA View system is indicated to acquire axial volumes of the whole body including the head. Images can be acquired in axial, helical, or dynamic modes. The SCENARIA View system can also be used for interventional needle guidance.
Volume datasets acquired by a SCENARIA View system can be post-processed in the SCENARIA View system to provide additional information. Post-processing capabilities of the SCENARIA View software include, multi-planar reconstruction (MPR), and volume rendering.
Volume datasets acquired by a SCENARIA View system can be transferred to external devices via a DICOM standard interface.
The Low Dose CT Lung Cancer Screening Option for the SCENARIA View system is indicated for using low dose CT for lung cancer screening must be conducted with the established program criteria and protocols that have been approved and published by a governmental body, a professional medical society, and/or Hitachi.
The SCENARIA View is a multi-slice computed tomography system that uses x-ray data to produce cross-sectional images of the body at various angles. The SCENARIA View system uses 128-slice CT technology, where the X-ray tube and detector assemblies are mounted on a frame that rotates continuously around the patient using slip ring technology. The solid-state detector assembly design collects up to 64 slices of data simultaneously. The X-ray sub-system features a high frequency generator, X-ray tube, and collimation system that produces a fan beam X-ray output. The system can operate in a helical (spiral) scan mode where the patient table moves during scanning. As the X-ray tube/detector assembly rotates around the patient, data is collected at multiple angles. The collected data is then reconstructed into cross-sectional images by a high-speed reconstruction sub-system. The images are displayed on a Computer Workstation, stored, printed, and archived as required. The workstation is based on current PC technology using the Windows™ operating system. The SCENARIA View system consists of a Gantry, Operator's Workstation, Patient Table, High-Frequency X-ray Generator, and accessories.
The provided text details the 510(k) premarket notification for the Hitachi SCENARIA View computed tomography x-ray system (K190841). The core of the submission focuses on demonstrating substantial equivalence to a predicate device, the SCENARIA Phase 3 (K150595).
Based on the provided document, here's an analysis of the acceptance criteria and the study that proves the device meets them:
1. A table of acceptance criteria and the reported device performance
The document does not explicitly present a table of quantitative acceptance criteria for the overall device performance in the sense of a new AI/software component with specific clinical performance metrics (e.g., sensitivity, specificity for a diagnostic task). Instead, the acceptance criteria are implicitly tied to demonstrating that the SCENARIA View system performs comparably to its predicate device (SCENARIA Phase 3) and meets established industry standards for CT systems.
The performance characteristics evaluated and reported are typically those for CT imaging systems, rather than AI-specific metrics. The document states:
| Performance Characteristic | Acceptance Criteria (Implicit) | Reported Device Performance |
|---|---|---|
| Clinical Equivalence | Device is substantially equivalent to predicate device (SCENARIA Phase 3) for general CT imaging. | A clinical evaluation comparison was conducted with the SCENARIA View system and the SCENARIA Phase 3 System (K150595) and found to be substantially equivalent. |
| Lung Screening Option | Performance comparable to the predicate evaluated in K180901 (HiMAR, Intelli IPV) for lung cancer screening image quality metrics. | Bench testing was conducted to demonstrate that the SCENARIA View is substantially equivalent to the predicate evaluated in K180901 (in terms of image quality metrics such as CT number accuracy, uniformity, noise, etc...) for the task of lung cancer screening. (This specifically relates to the "Low Dose CT Lung Cancer Screening Option" feature, which references technology cleared in a prior 510(k) K180901). The new iterative reconstruction technique, Intelli IPV, was added. HiMAR (metal artifact reduction technique) has been added which was cleared on the Supria True 64 (K171738). The Lung Screening Option is available on the SCENARIA View, which was cleared in K180901. "Bench testing was conducted to demonstrate that the SCENARIA View is substantially equivalent to the predicate evaluated in K180901 (in terms of image quality metrics such as CT number accuracy, uniformity, noise, etc...) for the task of lung cancer screening." |
| CT System Performance | Compliance with relevant standards and comparable performance to predicate for core CT metrics. | Evaluations were conducted for dose profile, image noise, Modulation Transfer Function (MTF), slice thickness and sensitivity profile, slice plane location, and CT dose index. "These tests and results support inclusion of the Lung Screening Option on the SCENARIA View." The device complies with all applicable requirements for Dose Profile, Noise, Mean CT number and Uniformity, Spatial Resolution, Tomographic Section Thickness and Sensitivity Profile, Tomographic Plane Location, and CT dose index. |
| Clinical Image Quality | Clinical images are diagnostic and meet user needs. | Hitachi has conducted a clinical image study of the head, chest, abdomen, and shoulder that includes an evaluation. In addition, a clinical study was conducted with the Intelli IPV, FBP, and HiMAR features which also includes evaluations. "Therefore, based on a thorough analysis and of the clinical images Hitachi believes the SCENARIA View is diagnostic and meet the user needs." |
| Safety and Effectiveness | Substantially equivalent to predicate in terms of safety and effectiveness. | "Therefore, based on a thorough analysis and comparison of the functions, scientific concepts, physical and performance characteristics, performance comparison and technological characteristics, the proposed SCENARIA View Whole-body X-ray CT System is considered substantially equivalent to the currently marketed predicate device (SCENARIA View Whole-body X-ray CT System (K171738)) in terms of design features, fundamental scientific technology, indications for use, and safety and effectiveness." |
2. Sample size used for the test set and the data provenance
The document mentions "a clinical image study of the head, chest, abdomen, and shoulder" and "a clinical study was conducted with the Intelli IPV, FBP, and HiMAR features". However, it does not specify the sample size (number of patients or images) used in these clinical studies or bench tests for the test set.
The data provenance (e.g., country of origin, retrospective or prospective) is also not specified in the provided text.
3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
The document states, "Therefore, based on a thorough analysis and of the clinical images Hitachi believes the SCENARIA View is diagnostic and meet the user needs." This implies an expert review, but it does not specify the number of experts, their qualifications, or the methodology they used to establish ground truth or evaluate the "diagnosticity" or "user needs."
4. Adjudication method (e.g. 2+1, 3+1, none) for the test set
The document does not specify any adjudication method used for reviewing the clinical images or test sets.
5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
The document does not indicate that an MRMC study was performed. The evaluation focuses on the system's inherent performance and its substantial equivalence to a predicate, not on human reader performance with or without AI assistance. The "Intelli IPV" and "HiMAR" features are described as new iterative reconstruction and metal artifact reduction techniques, respectively, which are intrinsic image processing methods of the CT system rather than assistive AI tools for human interpretation in the common sense of an AI CAD (Computer-Aided Detection) or CADx (Computer-Aided Diagnosis) system.
6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done
The entire submission focuses on the performance of the integrated CT system (SCENARIA View) which includes its image acquisition and reconstruction algorithms. Therefore, the "evaluations were conducted for dose profile, image noise, Modulation Transfer Function (MTF), slice thickness and sensitivity profile, slice plane location, and CT dose index" and "bench testing...in terms of image quality metrics such as CT number accuracy, uniformity, noise" can be considered forms of standalone algorithmic performance assessment based on objective phantom and image quality metrics. The "clinical image study" also evaluates the system's output directly.
7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)
For the technical performance evaluations (dose profile, noise, MTF, etc.), the ground truth relies on physical phantom measurements and engineering specifications/standards.
For the "clinical image study," the ground truth implicitly relies on expert subjective assessment of image diagnosticity and ability to meet user needs, "based on a thorough analysis and of the clinical images Hitachi believes the SCENARIA View is diagnostic and meet the user needs." There is no mention of pathology or outcomes data as ground truth.
8. The sample size for the training set
The document does not describe a "training set" in the context of an AI model being developed from scratch. The "Intelli IPV" and "HiMAR" are advanced image reconstruction techniques, which are typically developed using a combination of physics models, empirical data, and potentially machine learning techniques, but the document does not disclose details about any training data or its sample size for these specific features. The device's substantial equivalence is demonstrated against an existing predicate CT system, which implies that its fundamental design and performance are already established, rather than being a de novo AI system requiring a separate training and validation set disclosure in this context.
9. How the ground truth for the training set was established
As no specific training set for a new AI model is described, there's no information on how its ground truth was established. The performance of the image reconstruction algorithms (Intelli IPV, HiMAR) would have been validated against various phantom and clinical datasets to ensure they produce images of acceptable diagnostic quality, likely benchmarked against existing reconstruction methods and assessed by image quality experts. However, the specifics of this process are not detailed in the provided K190841 summary.
{0}------------------------------------------------
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). On the left is the Department of Health & Human Services logo. To the right of that is the FDA logo, which consists of the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG" in blue, with the word "ADMINISTRATION" underneath in a smaller font.
September 13, 2019
Hitachi Healthcare Americas % Mr. Aaron Pierce Director, RA/QA 1959 Summit Commerce Park TWINSBURG OH 44087
Re: K190841
Trade/Device Name: SCENARIA View Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: Class II Product Code: JAK Dated: August 9, 2019 Received: August 12, 2019
Dear Mr. Pierce:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part
{1}------------------------------------------------
801); medical device reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about mediation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatoryassistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
Thalia T. Mills, Ph.D. Director Division of Radiological Health OHT7: Office of In Vitro Diagnostics and Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
Indications for Use
510(k) Number (if known)
K190841
Device Name SCENARIA View
Indications for Use (Describe)
The SCENARIA View system is indicated to acquire axial volumes of the whole body including the head. Images can be acquired in axial, helical, or dynamic modes. The SCENARIA View system can also be used for interventional needle guidance.
Volume datasets acquired by a SCENARIA View system can be post-processed in the SCENARIA View system to provide additional information. Post-processing capabilities of the SCENARIA View software include, multi-planar reconstruction (MPR), and volume rendering.
Volume datasets acquired by a SCENARIA View system can be transferred to external devices via a DICOM standard interface.
The Low Dose CT Lung Cancer Screening Option for the SCENARIA View system is indicated for using low dose CT for lung cancer screening must be conducted with the established program criteria and protocols that have been approved and published by a governmental body, a professional medical society, and/or Hitachi.
Type of Use (Select one or both, as applicable)X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
{3}------------------------------------------------
Section 5 510(k) Statement or Summary
Submitter Information
| Submitter: | Hitachi Healthcare Americas1959 Summit Commerce ParkTwinsburg, Ohio 44087-2371 |
|---|---|
| Contact: | Aaron Pierce |
| Telephone number: | 330-425-1313 |
| Telephone number: | 330-963-0749 |
| E-mail: | piercea@hitachihealthcare.com |
| Date: | November 20, 2018 |
| Subject Device Name | |
| Trade/Proprietary Name: | SCENARIA View |
| Regulation Number: | 21 CFR 892.1750 |
| Regulation Name: | Computed tomography x-ray system |
| Product Code | JAK, System, X-Ray, Tomography, Computed |
| Class | II |
| Panel | Radiology |
| Predicate Device Name | |
| Predicate Device(s): | SCENARIA Phase 3 Whole-Body X-ray CT System (K150595) |
| Regulation Number: | 21 CFR 892.1750 |
| Regulation Name: | Computed tomography x-ray system |
| Product Code | JAK, System, X-Ray, Tomography, Computed |
| Class | II |
| Panel | Radiology |
Indications for Use
The SCENARIA View system is indicated to acquire axial volumes of the whole body including the head. Images can be acquired in axial, helical, or dynamic modes. The SCENARIA View system can also be used for interventional needle quidance.
Volume datasets acquired by a SCENARIA View system can be post-processed in the SCENARIA View system to provide additional information. Post-processing capabilities of the SCENARIA View software include, multi-planar reconstruction (MPR), and volume rendering.
Volume datasets acquired by a SCENARIA View system can be transferred to external devices via a DICOM standard interface.
The Low Dose CT Lung Cancer Screening Option for the SCENARIA View system is indicated for using low dose CT for lung cancer screening must be conducted with the established program criteria and protocols that have been approved and published by a governmental body, a professional medical society, and/or Hitachi.
Device Description
Function
The SCENARIA View is a multi-slice computed tomography system that uses x-ray data to produce cross-sectional images of the body at various angles.
{4}------------------------------------------------
Scientific Concepts
The SCENARIA View system uses 128-slice CT technology, where the X-ray tube and detector assemblies are mounted on a frame that rotates continuously around the patient using slip ring technology. The solid-state detector assembly design collects up to 64 slices of data simultaneously. The X-ray sub-system features a high frequency generator, X-ray tube, and collimation system that produces a fan beam X-ray output. The system can operate in a helical (spiral) scan mode where the patient table moves during scanning. As the X-ray tube/detector assembly rotates around the patient, data is collected at multiple angles,
The collected data is then reconstructed into cross-sectional images by a high-speed reconstruction sub-system. The images are displayed on a Computer Workstation, stored, printed, and archived as required. The workstation is based on current PC technology using the Windows™ operating system.
Physical and Performance Characteristics
The SCENARIA View system consists of a Gantry, Operator's Workstation, Patient Table, High-Frequency X-ray Generator, and accessories. The system performance is similar to the predicate device.
Performance Comparison
A clinical evaluation comparison was conducted with the SCENARIA View system and the SCENARIA Phase 3 System (K150595) and found to be substantially equivalent.
In addition, evaluations were conducted for dose profile, image noise, Modulation Transfer Function (MTF), slice thickness and sensitivity profile, slice plane location, and CT dose index. These tests and results support inclusion of the Lung Screening Option on the SCENARIA View.
The evaluation results confirm the performance characteristics of the SCENARIA View are comparable to the predicate device and support our conclusion that the subject system is substantially equivalent.
Device Technological Characteristics
| Systems | SCENARIA ViewSubject Device | SCENARIA Phase 3 (K150595)Predicate Device |
|---|---|---|
| Physical characteristics | ||
| Gantry | The gantry aperture is expanded to 850 mm by gantry design change. | |
| • Gantry Aperture | 800 [mm] | 750 [mm] |
| Detector | There are not differences between the two systems. | |
| X-ray Tube | There are not differences between the two systems. |
A summary of the differences is listed in the following table.
{5}------------------------------------------------
Image /page/5/Picture/0 description: The image shows the logo for Hitachi. The word "HITACHI" is written in large, bold, black letters. Below it, in a smaller font, is the phrase "Inspire the Next" also in black, except for a small red accent mark above the letter 't' in "Next".
| Systems | SCENARIA ViewSubject Device | SCENARIA Phase 3 (K150595)Predicate Device |
|---|---|---|
| X-ray Generator | There are not differences between the two systems. | |
| Patient Table | Patient Table specifications was revised with the expansion of Gantry aperture. | |
| • Range of Movement, Vertical | 490 to 970 [mm] (CT-WT-23)490 to 970 [mm] (CT-WT-22) | 465 to 1,050 [mm] (CT-WT-19)150 to 1,050 [mm] (CT-WT-18L) |
| • Range of Movement, Lateral | 1,750 [mm]2,000 [mm] (Extended Op.) | 1,750 [mm]2,000 [mm] (Extended Op.) |
| Display | There are not differences between the two systems. | |
| Image Storage | The hard disk capacity and image storage was increased. | |
| • Hard Disk | 1 [TB] (Image)3 [TB] (Raw Data) | 250 [GB] (Image)750 [GB] (Raw Data) |
| • Storage Images | 600,000 | 200,000 |
| Scanning, Reconstruction | The 15 mm collimation was eliminated. | |
| • Collimation | 1.25, 5, 10, 20, 40 [mm] | 1.25, 5, 10, 15, 20, 40 [mm] |
| Performance | There are not differences between the two systems. | |
| Dose Controls | The new iterative reconstruction technique, Intelli IPV was added. | |
| • Iterative Reconstruction | Yes (Intelli IP Advanced, Intelli IPV) | Yes (Intelli IP Advanced) |
| Dose Displays | There are not differences between the two systems. | |
| Features | The new Axial Shuttle Scan and Dual Energy Scan features have been added. HiMAR (metalartifact reduction technique) has been added which was cleared on the Supria True 64(K171738).The Lung Screening Option is available on the SCENARIA View, which was cleared inK180901. The bench testing was conducted to demonstrate that the SCENARIA View issubstantially equivalent to the predicate evaluated in K180901 (in terms of image qualitymetrics such as CT number accuracy, uniformity, noise, etc...) for the task of lung cancerscreening. |
Therefore, based on a thorough analysis and comparison of subject device (SCENARIA View) and the predicate device, the technological characteristics do not impact safety and effectiveness.
{6}------------------------------------------------
Image /page/6/Picture/0 description: The image contains the logo for Hitachi. The word "HITACHI" is written in large, bold, black letters. Below the company name is the slogan "Inspire the Next" in a smaller font, also in black. The letter "t" in the word "Next" has a small red accent mark.
Substantial Equivalence
A summary decision was based on a thorough analysis and comparison of the functions, scientific concepts, physical and performance characteristics, performance comparison and technological characteristics.
| ITEM | Overall Rationale Analysis |
|---|---|
| Gantry | There are no significant changes in the SCENARIA View from the predicate device which would affect safety or effectiveness. |
| Detector | |
| X-ray Tube | |
| X-ray Generator | |
| Patient Table | |
| Display | |
| Image Storage | |
| Scanning, | |
| Reconstruction | |
| Performance | |
| Dose Controls | |
| Dose Displays | |
| Features |
Therefore, based on a thorough analysis and comparison of the functions, scientific concepts, physical and performance characteristics, performance comparison and technological characteristics, the proposed SCENARIA View Whole-body X-ray CT System is considered substantially equivalent to the currently marketed predicate device (SCENARIA View Wholebody X-ray CT System (K171738)) in terms of design features, fundamental scientific technology, indications for use, and safety and effectiveness.
{7}------------------------------------------------
Image /page/7/Picture/0 description: The image contains the logo for Hitachi. The word "HITACHI" is written in large, bold, black letters. Below the company name is the slogan "Inspire the Next" in a smaller font size, also in black. The logo is simple and modern, with a focus on the company name and its message of innovation.
Summary of Non-Clinical Testing
This device complies with all applicable requirements for Dose Profile. Noise. Mean CT number and Uniformity, Spatial Resolution, Tomographic Section Thickness and Sensitivity Profile, Tomographic Plane Location, and CT dose index.
In addition, the SCENARIA View system is in conformance with the applicable parts of the following standards:
-
. AAMI ANSI ES60601-1:2005/(R) 2012 and A1:2012, C1:2009/(R)2012 and A2:2010/(R)2012
Medical electrical equipment - Part 1: General requirements for basic safety and essential performance (IEC 60601-1:2005, MOD) -
IEC 60601-1-2 Edition 4.0 .
Medical electrical equipment - Part 1-2: General requirements for basic safety and essential performance - Collateral standard: Electromagnetic compatibility - Requirements and tests -
IEC 60601-1-3 Edition 2.1 .
Medical electrical equipment - Part 1-3: General requirements for basic safety and essential performance - Collateral Standard: Radiation protection in diagnostic X-ray equipment -
IEC 60601-1-6 Edition 3.1
Medical electrical equipment - Part 1-6: General requirements for basic safety and essential performance - Collateral standard: Usability -
IEC 60601-2-44 Edition 3.1 Medical electrical equipment Part 2-44: particular requirements for the basic safety and essential performance of x-ray equipment for computed tomography.
-
. IEC 62304 Edition 1.1
Medical device software - Software life cycle processes
-
IEC 62366 Edition 1.1
Medical devices - Application of usability engineering to medical devices -
NEMA XR 25 Computed Tomography Dose Check
-
. NEMA XR29 Standard Attributes on CT Equipment Related to Dose Optimization and Manaqement
Summary of Clinical Testing
Hitachi has conducted a clinical image study of the head, chest, abdomen, and shoulder that includes an evaluation. In addition, a clinical study was conducted with the Intelli IPV, FBP, and HiMAR features which also includes evaluations. Therefore, based on a thorough analysis and of the clinical images Hitachi believes the SCENARIA View is diagnostic and meet the user needs.
Conclusions
Hitachi believes that, based on the information included in the submission, SCENARIA View Whole-body X-ray CT System is substantially equivalent with respect to hardware, base elements of the software, safety, effectiveness, and functionality to the SCENARIA Phase 3 Whole-Body X-ray CT System (K150595).
§ 892.1750 Computed tomography x-ray system.
(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.